Medindia

X

Marijuana Stocks Gaining Major Momentum in U.S. Ahead of Next Week's Elections

Wednesday, November 2, 2016 Drug News J E 4
Advertisement

NEW YORK, November 2, 2016 /PRNewswire/ --

As Americans head to the polls and aim to help pass legislation to increase legalization in Nine States in the U.S., cannabis stocks are betting on a large turn out to increase the industry's momentum already sweeping across both America and the globe.  The cannabis sector figures to continue its upward swing for Arcturus Growthstar Technologies Inc. (OTC: AGSTF), Cannabics Pharmaceuticals Inc. (OTC: CNBX), Medical Marijuana, Inc. (OTC: MJNA), American Cannabis Company, Inc. (OTC: AMMJ) and Growblox Sciences, Inc. (OTC: GBLX).

Arcturus Growthstar Technologies Inc. (OTCQB: AGSTF) (CSE: AGS.CN) is pleased to announce that it has engaged the services of Mr. Jim Coull to begin design and construction work at its flagship farm in North Kingstown, Rhode Island. Mr. Coull offers commercial design-build, general contracting and preconstruction services to the cleanroom laboratory, advanced technology, education and healthcare industries. He is known for his highly technical construction and turnkey services, from planning and feasibility through architecture, engineering, general contracting and commissioning. 

Read the full Arcturus (AGSTF) (AGS.CN) press release at: http://marketnewsupdates.com/news/agstf.html

The Company plans to use the Rhode Island farm to showcase its proprietary scalable, indoor Controlled Environment Agriculture (CEA) technology, which allows it to produce crops more cost effectively than traditional farming methods, without the use of chemical pesticides, all while using 90% less water and fertilizer. Mr. Coull has experience with Arcturus' CEA technology, and even helped to refine the CEA system by creating greater efficiencies during growth trial phases.

"We are excited to have Jim Coull and his team of construction professionals on board with us in the development and construction of our Rhode Island farm, which can grow both leafy greens and Cannabis" says Mr. William Gildea, Arcturus Growthstar Technologies, Inc.'s CEO and Chairman. "Mr. Coull's reputation for excellence and comprehensive construction management services will ensure our flagship farm's success."  Mr. Coull adds, "I am pleased to see this project is underway and look forward to help bring it to a successful conclusion. It will provide fresh organic produce to the Rhode Island Market on a one day 'harvest to table' basis. CEA is the coming trend in the food production business, and is of particular importance here in New England where our growing season is very short."  

Other Cannabis stocks performing well in the markets this week: 

Cannabics Pharmaceuticals Inc. (OTC Pink: CNBX) closed up over 33% at $0.83 Tuesday on over 2.97 Million shares traded by the market close.  CNBX announced recently that results from the company's latest cancer HTS research overtly conclude that, depending upon the THC/CBD ratio, specific Cannabis extracts are directly contributive to reducing U87MG glioblastoma cell viability. The Company expects that results on additional types of cancers will be attained during December 2016.

Medical Marijuana, Inc. (OTC Pink: MJNA) closed up over 14% on Tuesday at $0.1595 on over 76.6 Million shares traded by the market close.  MJNA yesterday announced that its portfolio company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has begun pharmacokinetic/pharmacodynamics (PK/PD) studies with its CanChew Plus® Gum, the first CBD hemp oil chewing gum, to ascertain the potential for a reduction of irritable bowel syndrome (IBS) symptoms in patients.

American Cannabis Company, Inc. (OTCQB: AMMJ) closed up on Tuesday as well at $1.75 or more than 12% up on over 5.026 Million shares traded by the market close.  AMMJ, a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, recently announced that it has secured a new design and consulting contract with a Canadian firm for the purpose of creating a cannabis Licensed Producer facility within the Atlantic provinces.

Growblox Sciences, Inc. (OTCQB: GBLX) closed up slightly on Tuesday at $0.59 on above average trading of over 3.22 Million shares traded by the market close.  GBLX recently announced the filing of the first of several patent applications for life science inventions by its wholly-owned subsidiary, Growblox Life Sciences, LLC.  The current provisional patent application covers complex-cannabinoid-containing mixtures capable of enhancing dopamine secretion and protect neurons from the mitochondrial-induced free radical damage that occurs during disease progression in the brains of patients with Parkinson's disease, Alzheimer's disease, Lewy Body Dementia, and Huntington's disease, among others. In an aging population, neurodegeneration associated with these disorders is a growing health burden according to the World Health Organization (2013).

DISCLAIMER:  MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  MNU is NOT affiliated in any manner with any company mentioned herein.  MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  MNU is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed MNU has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Arcturus Growthstar Technologies Inc. by the company.  MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information:

Media Contact email:  info@marketnewsupdates.com - +1(561)325-8757

SOURCE MarketNewsUpdates.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Health Dialog Earns NCQA Certification for 24/7 Nu...
S
Hemophilia Drugs Market to Grow at 4.76% CAGR to 2...